| Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults (NCT00989287) | GlaxoSmithKline | 2009-10-07 |
| Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) (NCT00989612) | GlaxoSmithKline | 2009-10-01 |
| A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection (NCT00979667) | Chinese University of Hong Kong | 2009-10-01 |
| Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza? (NCT01001325) | Mount Sinai Hospital, Canada | 2009-10-01 |
| Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth (NCT01484522) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2009-10-01 |
| Novel Influenza A (H1N1) Surveillance Registry (NCT01046331) | National Heart, Lung, and Blood Institute (NHLBI) | 2009-10-01 |
| Comparison of the Efficacy of Inflexal V With a Commercially Available Influenza Vaccine in Young Children (NCT01310400) | Crucell Holland BV | 2009-10-01 |
| Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections (NCT01728090) | Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental | 2009-10-01 |
| STIP: Statin Trial for Influenza Patients (NCT00970606) | Gordon Bernard | 2009-10-01 |
| "COhort Study on A/H1N1 FLU During PREGnancy" (NCT01192737) | Institut National de la Santé Et de la Recherche Médicale, France | 2009-10-01 |
| Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults (NCT00980447) | UMN Pharma Inc. | 2009-10-01 |
| A Study of Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly (NCT00952276) | Sanofi | 2009-10-01 |
| Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults (NCT01008137) | Sinovac Biotech Co., Ltd | 2009-10-01 |
| Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children (NCT01001169) | GlaxoSmithKline | 2009-10-01 |
| Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population (NCT01007201) | Adimmune Corporation | 2009-10-01 |
| Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients (NCT01055990) | Shanghai Public Health Clinical Center | 2009-10-01 |
| Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults (NCT00985673) | GlaxoSmithKline | 2009-10-01 |
| Safety of H1N1 Influenza Vaccination in Pregnant Women (NCT01842997) | Jiangsu Province Centers for Disease Control and Prevention | 2009-10-01 |
| A Study of Influenza Virus Vaccines in Children and Adults (NCT00988143) | Sanofi Pasteur, a Sanofi Company | 2009-10-01 |
| Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly (NCT00915187) | NasVax Ltd | 2009-10-01 |
| Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage (NCT01089400) | Institut National de la Santé Et de la Recherche Médicale, France | 2009-10-01 |
| Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months (NCT00996307) | Novartis Vaccines | 2009-10-01 |
| Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1 (NCT01006798) | Emergent BioSolutions | 2009-10-01 |
| Influenza Vaccine Safety and Effectiveness in Healthcare Providers (NCT01282177) | Dalhousie University | 2009-10-01 |
| Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children (NCT00972517) | GlaxoSmithKline | 2009-09-29 |
| Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines (NCT01191853) | National Heart, Lung, and Blood Institute (NHLBI) | 2009-09-18 |
| Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults (NCT00975884) | GlaxoSmithKline | 2009-09-14 |
| Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly (NCT00968890) | GlaxoSmithKline | 2009-09-12 |
| Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A) (NCT00964158) | GlaxoSmithKline | 2009-09-10 |
| Safety, Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A) (NCT00971321) | GlaxoSmithKline | 2009-09-10 |
| Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1) (NCT00971425) | GlaxoSmithKline | 2009-09-08 |
| Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults (NCT00968526) | GlaxoSmithKline | 2009-09-08 |
| Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults (NCT00968539) | GlaxoSmithKline | 2009-09-08 |
| Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years) (NCT00972816) | Novartis Vaccines | 2009-09-01 |
| Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM (NCT01011049) | Sanofi Pasteur, a Sanofi Company | 2009-09-01 |
| A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population (NCT00959049) | Seqirus | 2009-09-01 |
| Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age (NCT00966238) | VaxInnate Corporation | 2009-09-01 |
| Safety, Tolerability and Immunogenicity of Fluzone® With and Without JVRS-100 in Elderly Subjects (NCT00936468) | Colby Pharmaceutical Company | 2009-09-01 |
| Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects (NCT00996138) | Novartis Vaccines | 2009-09-01 |
| Swine Flu (Novel Influenza A H1N1) Vaccine Study (NCT00980850) | University of Oxford | 2009-09-01 |
| Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral Oseltamivir (NCT00980109) | University of Oxford | 2009-09-01 |
| Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Adults and Elders (NCT01003145) | Adimmune Corporation | 2009-09-01 |
| School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities (NCT01224301) | Monroe County Department of Public Health | 2009-09-01 |
| Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults (NCT00973349) | Novartis | 2009-09-01 |
| Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations (NCT00963157) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-09-01 |
| Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects (NCT00979251) | Adamas Pharmaceuticals, Inc. | 2009-09-01 |
| Outcomes of Pandemic Influenza in Pregnancy (NCT01322516) | Dalhousie University | 2009-09-01 |
| Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and Older (NCT00976027) | Sanofi | 2009-09-01 |
| T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009 (NCT01987349) | Stanford University | 2009-09-01 |
| H1N1 Vaccine in Pregnant Women (NCT00963430) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-09-01 |
| A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months (NCT00956046) | Sanofi Pasteur, a Sanofi Company | 2009-09-01 |
| Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children (NCT01100294) | Fluart Innovative Vaccine Ltd, Hungary | 2009-09-01 |
| Direct and Indirect Protection by Influenza Vaccine Given to Children in India (NCT00934245) | Wayne Sullender, M.D. | 2009-09-01 |
| Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults (NCT00951041) | GlaxoSmithKline | 2009-08-11 |
| A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age (NCT00946101) | MedImmune LLC | 2009-08-01 |
| A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA (NCT00958243) | Seqirus | 2009-08-01 |
| Collaborative Efforts to Increase Flu Vaccination (NCT01403649) | University of Colorado, Denver | 2009-08-01 |
| Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study (NCT00936013) | Capital Medical University | 2009-08-01 |
| A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years (NCT00952419) | Sanofi Pasteur, a Sanofi Company | 2009-08-01 |
| A/H1N1 Immunogenicity and Safety in Adults (NCT00959465) | Alachua Government Services, Inc. | 2009-08-01 |
| Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations (NCT00943631) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| Respiratory Virus Hospitalization Study (FLU 003 Plus) (NCT01056185) | University of Minnesota | 2009-08-01 |
| Sanofi Pasteur, TIV + H1N1, Pediatric Population (NCT00943202) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| Rapid Evaluation of Seasonal Influenza Vaccine (NCT00966342) | University of British Columbia | 2009-08-01 |
| A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years (NCT00956202) | Sanofi Pasteur, a Sanofi Company | 2009-08-01 |
| A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly (NCT00953524) | Sanofi Pasteur, a Sanofi Company | 2009-08-01 |
| A Study on Emergence of Resistance With Oseltamivir (Tamiflu) in Participants With Seasonal Influenza (NCT00949533) | Hoffmann-La Roche | 2009-08-01 |
| A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA (NCT00958126) | Seqirus | 2009-08-01 |
| CSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations (NCT00943488) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels (NCT00944073) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine (NCT01010893) | Fluart Innovative Vaccine Ltd, Hungary | 2009-08-01 |
| Sanofi H1N1 + TIV - Adults and Elderly (NCT00943878) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-08-01 |
| A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly (NCT00954798) | Sanofi Pasteur, a Sanofi Company | 2009-08-01 |
| Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly (NCT00938392) | GlaxoSmithKline | 2009-07-30 |
| The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine (NCT01336166) | Shanghai Institute Of Biological Products | 2009-07-01 |
| Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older (NCT00975572) | Jiangsu Province Centers for Disease Control and Prevention | 2009-07-01 |
| Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study (NCT00935194) | Capital Medical University | 2009-07-01 |
| Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults (NCT00921726) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-07-01 |
| Safety and Immunogenicity of A/H1N1v Vaccines in Healthy Adults (NCT00943358) | University Hospitals, Leicester | 2009-07-01 |
| A Clinical Trial With Influenza A/H1N1 Vaccines (NCT00956111) | Sinovac Biotech Co., Ltd | 2009-07-01 |
| B-cell Immunity to Influenza (SLVP017)- Year 1, 2009 (NCT02133781) | Stanford University | 2009-07-01 |
| A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults (NCT00920374) | GlaxoSmithKline | 2009-06-16 |
| A Study to Assess the Safety and Efficacy of a New Influenza Candidate Vaccine MVA-NP+M1 In Healthy Adults (NCT00993083) | University of Oxford | 2009-06-01 |
| Safety of VAX102 Vaccine Given With Seasonal Flu Vaccine in Healthy Adults (NCT00921973) | VaxInnate Corporation | 2009-06-01 |
| Influenza Vaccine in Pregnant Women (NCT00905125) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-06-01 |
| Study to Investigate the Immune Response to Two Doses of VAX102 Healthy Adults (NCT00921206) | VaxInnate Corporation | 2009-06-01 |
| Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects (NCT00956449) | Novartis | 2009-06-01 |
| Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 09/10 Season (NCT00881842) | Abbott Biologicals | 2009-06-01 |
| A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Virus Strains for the Northern Hemisphere (NCT01306253) | Crucell Holland BV | 2009-06-01 |
| Yearly Strain Variation Study, 2009/2010 (NCT00943657) | Alachua Government Services, Inc. | 2009-06-01 |
| Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (NCT00946179) | Sanofi Pasteur, a Sanofi Company | 2009-05-01 |
| Inactivated Influenza Vaccine Effectiveness in Tropical Africa (NCT00893906) | PATH | 2009-05-01 |
| Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza (NCT01693380) | Butantan Institute | 2009-05-01 |
| MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use (NCT01050465) | University of Missouri-Columbia | 2009-05-01 |
| Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route) (NCT00945438) | Sanofi Pasteur, a Sanofi Company | 2009-05-01 |
| Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination (NCT00889889) | Abbott Biologicals | 2009-05-01 |
| A Study to Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy Volunteers (NCT00888381) | Seqirus | 2009-05-01 |
| Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children (NCT00884182) | Sanofi Pasteur, a Sanofi Company | 2009-04-01 |
| Safety, Tolerability and Pharmacokinetic Study of Multiple Doses of CS-8958 (NCT00995826) | Biota Scientific Management Pty Ltd | 2009-04-01 |
| A Study of the Pharmacology of Oseltamivir (Tamiflu) in Pregnancy (NCT00873886) | University of Pittsburgh | 2009-04-01 |